ClinicalTrials.govpublic full text
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
advanced lung non-small cell carcinoma, metastatic lung non-small cell carcinoma, stage iv lung cancer ajcc v8, stage iva lung cancer ajcc v8, stage ivb lung cancer ajcc v8, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839881
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.